Literature DB >> 30237260

Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis.

Rafael Diaz de la Guardia1, Belen Lopez-Millan1, Heleia Roca-Ho1, Clara Bueno1, Francisco Gutiérrez-Agüera1, Jose Luis Fuster2, Eduardo Anguita3, Samanta Romina Zanetti1, Susana Vives4, Josep Nomdedeu5, Robert Sackstein6, Jessie Lavoie7, Elena Gónzalez-Rey8, Mario Delgado8, Michael Rosu-Myles7, Pablo Menendez9,10,11.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30237260      PMCID: PMC6355484          DOI: 10.3324/haematol.2018.196568

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.

Authors:  Pingnan Xiao; Lakshmi Sandhow; Yaser Heshmati; Makoto Kondo; Thibault Bouderlique; Monika Dolinska; Anne-Sofie Johansson; Mikael Sigvardsson; Marja Ekblom; Julian Walfridsson; Hong Qian
Journal:  Blood Adv       Date:  2018-06-26

2.  Self-renewing human bone marrow mesenspheres promote hematopoietic stem cell expansion.

Authors:  Joan Isern; Beatriz Martín-Antonio; Roshanak Ghazanfari; Ana M Martín; Juan A López; Raquel del Toro; Abel Sánchez-Aguilera; Lorena Arranz; Daniel Martín-Pérez; María Suárez-Lledó; Pedro Marín; Melissa Van Pel; Willem E Fibbe; Jesús Vázquez; Stefan Scheding; Álvaro Urbano-Ispizúa; Simón Méndez-Ferrer
Journal:  Cell Rep       Date:  2013-04-25       Impact factor: 9.423

3.  Functional Niche Competition Between Normal Hematopoietic Stem and Progenitor Cells and Myeloid Leukemia Cells.

Authors:  Chen Glait-Santar; Ronan Desmond; Xingmin Feng; Taha Bat; Jichun Chen; Elisabeth Heuston; Benjamin Mizukawa; James C Mulloy; David M Bodine; Andre Larochelle; Cynthia E Dunbar
Journal:  Stem Cells       Date:  2015-10-05       Impact factor: 6.277

4.  Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis.

Authors:  E Gonzalez-Rey; P Anderson; M A González; L Rico; D Büscher; M Delgado
Journal:  Gut       Date:  2009-01-09       Impact factor: 23.059

5.  Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche.

Authors:  Maher Hanoun; Dachuan Zhang; Toshihide Mizoguchi; Sandra Pinho; Halley Pierce; Yuya Kunisaki; Julie Lacombe; Scott A Armstrong; Ulrich Dührsen; Paul S Frenette
Journal:  Cell Stem Cell       Date:  2014-07-10       Impact factor: 24.633

Review 6.  Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool.

Authors:  J García-Castro; C Trigueros; J Madrenas; J A Pérez-Simón; R Rodriguez; P Menendez
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

7.  Human bone marrow stromal cells lose immunosuppressive and anti-inflammatory properties upon oncogenic transformation.

Authors:  Rene Rodriguez; Michael Rosu-Myles; Marcos Aráuzo-Bravo; Angélica Horrillo; Qiuwei Pan; Elena Gonzalez-Rey; Mario Delgado; Pablo Menendez
Journal:  Stem Cell Reports       Date:  2014-09-11       Impact factor: 7.765

8.  Mesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular Mechanisms.

Authors:  Annette K Brenner; Ina Nepstad; Øystein Bruserud
Journal:  Front Immunol       Date:  2017-02-09       Impact factor: 7.561

9.  Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.

Authors:  Rafael Diaz de la Guardia; Belen Lopez-Millan; Jessie R Lavoie; Clara Bueno; Julio Castaño; Maite Gómez-Casares; Susana Vives; Laura Palomo; Manel Juan; Julio Delgado; Maria L Blanco; Josep Nomdedeu; Alberto Chaparro; Jose Luis Fuster; Eduardo Anguita; Michael Rosu-Myles; Pablo Menéndez
Journal:  Stem Cell Reports       Date:  2017-05-18       Impact factor: 7.765

10.  Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease.

Authors:  Belen Lopez-Millan; Rafael Diaz de la Guardia; Heleia Roca-Ho; Carmen M García-Herrero; Jessie R Lavoie; Michael Rosu-Myles; Elena Gonzalez-Rey; Francisco O'Valle; Gabriel Criado; Mario Delgado; Pablo Menendez
Journal:  Exp Mol Med       Date:  2017-02-03       Impact factor: 8.718

View more
  9 in total

1.  Robust In Vitro and In Vivo Immunosuppressive and Anti-inflammatory Properties of Inducible Caspase-9-mediated Apoptotic Mesenchymal Stromal/Stem Cell.

Authors:  Paola Alejandra Romecín; Meritxell Vinyoles; Belén López-Millán; Rafael Diaz de la Guardia; Noemi M Atucha; Sergi Querol; Clara Bueno; Raquel Benitez; Elena Gonzalez-Rey; Mario Delgado; Pablo Menéndez
Journal:  Stem Cells Transl Med       Date:  2022-03-03       Impact factor: 7.655

2.  The role of resveratrol in bone marrow-derived mesenchymal stem cells from patients with osteoporosis.

Authors:  Jing Li; Zhaoxu Xin; Mingjun Cai
Journal:  J Cell Biochem       Date:  2019-05-20       Impact factor: 4.429

3.  Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemia.

Authors:  Jiali Huo; Leisheng Zhang; Xiang Ren; Chengwen Li; Xingxin Li; Peiyuan Dong; Xuan Zheng; Jinbo Huang; Yingqi Shao; Meili Ge; Jing Zhang; Min Wang; Neng Nie; Peng Jin; Yizhou Zheng
Journal:  Stem Cell Res Ther       Date:  2020-02-13       Impact factor: 6.832

4.  High-efficient generation of VCAM-1+ mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice.

Authors:  Yimeng Wei; Leisheng Zhang; Ying Chi; Xiang Ren; Yuchen Gao; Baoquan Song; Chengwen Li; Zhibo Han; Lei Zhang; Zhongchao Han
Journal:  Cell Prolif       Date:  2020-06-29       Impact factor: 6.831

5.  Adipose-Derived Stem Cells From Patients With Ulcerative Colitis Exhibit Impaired Immunosuppressive Function.

Authors:  Xiaoyun Wu; Yongxu Mu; Jingyi Yao; Fuhong Lin; Daocheng Wu; Zhijie Ma
Journal:  Front Cell Dev Biol       Date:  2022-02-18

6.  Engraftment characterization of risk-stratified AML in NSGS mice.

Authors:  Rafael Díaz de la Guardia; Talía Velasco-Hernandez; Francisco Gutiérrez-Agüera; Heleia Roca-Ho; Oscar Molina; Cesar Nombela-Arrieta; Alex Bataller; Jose Luis Fuster; Eduardo Anguita; Susana Vives; Lurdes Zamora; Josep Nomdedeu; María Teresa Gómez-Casares; Manuel Ramírez-Orellana; Helene Lapillonne; Verónica Ramos-Mejia; Juan Carlos Rodríguez-Manzaneque; Clara Bueno; Belen Lopez-Millan; Pablo Menéndez
Journal:  Blood Adv       Date:  2021-12-14

7.  Effects of Resveratrol, Curcumin and Quercetin Supplementation on Bone Metabolism-A Systematic Review.

Authors:  Alessio Danilo Inchingolo; Angelo Michele Inchingolo; Giuseppina Malcangi; Pasquale Avantario; Daniela Azzollini; Silvio Buongiorno; Fabio Viapiano; Merigrazia Campanelli; Anna Maria Ciocia; Nicole De Leonardis; Elisabetta de Ruvo; Irene Ferrara; Grazia Garofoli; Valentina Montenegro; Anna Netti; Giulia Palmieri; Antonio Mancini; Assunta Patano; Fabio Piras; Grazia Marinelli; Chiara Di Pede; Claudia Laudadio; Biagio Rapone; Denisa Hazballa; Alberto Corriero; Maria Celeste Fatone; Andrea Palermo; Felice Lorusso; Antonio Scarano; Ioana Roxana Bordea; Daniela Di Venere; Francesco Inchingolo; Gianna Dipalma
Journal:  Nutrients       Date:  2022-08-26       Impact factor: 6.706

8.  Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.

Authors:  Samanta Romina Zanetti; Paola Alejandra Romecin; Meritxell Vinyoles; Manel Juan; José Luis Fuster; Mireia Cámos; Sergi Querol; Mario Delgado; Pablo Menendez
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

9.  The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia.

Authors:  Belen Lopez-Millan; Paula Costales; Francisco Gutiérrez-Agüera; Rafael Díaz de la Guardia; Heleia Roca-Ho; Meritxell Vinyoles; Alba Rubio-Gayarre; Rémi Safi; Julio Castaño; Paola Alejandra Romecín; Manuel Ramírez-Orellana; Eduardo Anguita; Irmela Jeremias; Lurdes Zamora; Juan Carlos Rodríguez-Manzaneque; Clara Bueno; Francisco Morís; Pablo Menendez
Journal:  Cancers (Basel)       Date:  2022-03-21       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.